NCT06651970 2026-02-23Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart FailureAstraZenecaPhase 4 Recruiting60 enrolled
NCT01990534 2021-04-09A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaTakedaPhase 4 Completed60 enrolled 21 charts